INVO Fertility (IVF) Net Cash Flow (2011 - 2026)

INVO Fertility (IVF) has 16 years of Net Cash Flow data on file, last reported at $2.8 million in Q1 2026.

• On a quarterly basis, Net Cash Flow rose 2754.85% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $2.3 million, a 541.18% increase from a year earlier, with the FY2024 full-year figure at $508972.0, up 257.7% from the prior year.
• Net Cash Flow for Q1 2026 stood at $2.8 million, up from -$156445.0 in the prior quarter.
• Over the last five years, Net Cash Flow for IVF reached as high as $2.8 million in Q1 2026 and fell as low as -$2.1 million in Q2 2023.
• Historically, Net Cash Flow has averaged -$156397.9 across 5 years, with a median of -$176003.5 in 2022.
• Across the five-year window, Net Cash Flow tumbled 320.9% in 2023 and soared 2754.85% in 2026, its largest moves.
• Year by year, Net Cash Flow stood at -$195562.0 in 2022, then tumbled by 320.9% to -$823120.0 in 2023, then soared by 132.78% to $269805.0 in 2024, then tumbled by 157.98% to -$156445.0 in 2025, then jumped by 1906.78% to $2.8 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $2.8 million in Q1 2026, -$156445.0 in Q3 2025, and -$328071.0 in Q2 2025.